RightAnswer Knowledge Solutions Search Results for 7683-36-5

New Search  |  Search Results (7683-36-5 )  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp


All Other Data Sources:

RTECS® Registryhelp

ChemID External Links:

DARThelp
Obidoxime
DrugPortalhelp
Obidoxime
eChemPortalhelp
Obidoxime
EPA ACToRhelp
Obidoxime
MeSHhelp
Obidoxime
PubChemhelp
Obidoxime
PubMedhelp
Obidoxime
PubMed Cancerhelp
Obidoxime
PubMed Toxicologyhelp
Obidoxime
TOXLINEhelp
Obidoxime
USA.govhelp
Obidoxime

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 7683-36-5 :


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. WITH THERAPEUTIC USE
    1. Hypertension, tachycardia, pain at the injection site, flushing, drowsiness, dry mouth, a menthol-like taste, nausea and vomiting, headache, generalized weakness, elevated liver enzyme levels, and facial paresthesias have been reported following therapeutic administration of obidoxime.
  1. WITH POISONING/EXPOSURE
    1. Overdose information is limited. Hepatotoxicity, with rare cases of fatal liver failure, has been reported following administration of large cumulative doses of obidoxime.
© 2011-2017 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.